Q3 Adjusted EPS of $1.22 Misses Estimates as Revenue Falls 20%
CRBG sits 61% above its 52-week low of $22.19 on elevated volume (1.8× avg).
Summary
Adjusted EPS came in at $1.22, a penny below the $1.24 consensus, and revenue dropped 20% to $4.50 billion against $5.08 billion expected — a wide top-line miss. Reported net income was $1.44 billion, or $3.22 per diluted share, inflated by items below the operating line. The operating figure was still up from 96 cents a year ago, and the stock has run 18.5% this year into a 52-week high, so the bar was high. Four analysts cut estimates in the last 30 days, and the consensus rating remains buy with a $40 median target. The 10-Q filed November 3 shows AOCI deepening to a $15.2 billion loss as rising rates hit the bond portfolio, which is the balance-sheet item to weigh against the pending Equitable merger.
At the time of this announcement, CRBG was trading at $35.74 on NYSE in the Finance sector, with a market capitalization of approximately $15.9B. The 52-week trading range was $22.19 to $36.56. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.